| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 19.76 Billion | USD 59.53 Billion | 11.66% | 2024 |
The global self-monitoring blood glucose devices market size was worth around USD 19.76 Billion in 2024 and is predicted to grow to around USD 59.53 Billion by 2034 with a compound annual growth rate (CAGR) of roughly 11.66% between 2025 and 2034.
The report analyzes the global self-monitoring blood glucose devices market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the self-monitoring blood glucose devices industry.
Blood glucose monitoring helps patients with diabetes make daily management decisions such as insulin dose, food intake, and physical exercise. Self-monitoring blood glucose (SMBG) is an advanced diabetes management procedure. It includes using blood glucose metrics by patients to check their respective glucose levels and provide an appropriate measure of capillary glucose concentration.Self-monitoring blood glucose technology uses lancets, test strips, and blood glucose meters to achieve long-term glycemic control. The growth of self-monitoring blood glucose devices can be attributed to factors such as an increase in risk factors that lead to diabetes and a rise in the incidence rate of diabetes. However, blood glucose monitoring devices have some shortcomings. They do not measure the exact glucose level in the blood and can give inaccurate results, thereby hampering the market growth.
Increasing awareness regarding the use of self-monitoring blood glucose devices to drive the market growth
Self-monitoring blood glucose devices are predicted to showcase a high growth rate. Self-monitoring blood glucose devices are witnessing robust advances along with several launches by major players. Moreover, demand for self-monitoring blood glucose devices increased due to a rise in awareness regarding the usage of self-monitoring blood glucose devices and their benefits. Additionally, the rise in the geriatric population and technological advancements in blood glucose monitoring devices will boost the growth of the global self-monitoring blood glucose devices market.
Shortcomings of self-monitoring blood glucose devices hinder the market growth
Self-monitoring blood glucose devices have shortcomings, such as not measuring the exact blood glucose level and can give inaccurate results, which hampers the market growth.
Technological advancements to present market opportunities
Technological advancements in the self-monitoring blood glucose devices owing to an increase in the adoption of these technologies to manage diabetes will provide opportunities for key players in the global self-monitoring blood glucose devices market. At the same time, increasing awareness of diabetes monitoring devices is expected to promote the market's growth.
High cost of self-monitoring blood glucose devices
The cost of self-monitoring blood glucose devices is high, and it is still difficult for many target customers to afford them. Hence, the self-monitoring blood glucose devices market is stagnant in countries with lower disposable income and low purchasing power.
| Report Attributes | Report Details |
|---|---|
| Report Name | Self-Monitoring Blood Glucose Devices Market |
| Market Size in 2024 | USD 19.76 Billion |
| Market Forecast in 2034 | USD 59.53 Billion |
| Growth Rate | CAGR of 11.66% |
| Number of Pages | 254 |
| Key Companies Covered | Abbott Laboratories, Dexcom, Medtronic, Roche, Ascensia Diabetes Care, Senseonics, Nemaura Medical, Know Labs, BioXensor, DiaMonTech, and others. |
| Segments Covered | By Product, By Application, By End User, By Distribution Channel, and By Region |
| Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, The Middle East and Africa (MEA) |
| Base Year | 2024 |
| Historical Year | 2020 - 2023 |
| Forecast Year | 2025 - 2034 |
| Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
North America dominated the self-monitoring blood glucose devices market in 2034
North America acquired a major share of the global self-monitoring blood glucose devices market in 2021 due to the region's high incidence rate of diabetes. Moreover, the presence of key players in North America promotes the market's growth. Further, the constantly evolving healthcare industry drives the market growth in this region.
The CDC estimates that 34.2 million Americans will have diabetes in 2020, and one in three people in the country have prediabetes. The patient base is further augmented by obesity, unhealthful eating patterns, and other environmental variables. The industry's expansion will also be fueled by several initiatives launched by national and international organizations to lower the disease burden.
The report provides a company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market, including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the self-monitoring blood glucose devices market on a global and regional basis.
The global self-monitoring blood glucose devices market is dominated by players like:
By Product
By Application
By End User
By Distribution Channel
By Region
FrequentlyAsked Questions
The global self-monitoring blood glucose devices market is expected to grow due to rising prevalence of diabetes, increasing health awareness, and demand for portable, real-time glucose monitoring solutions.
According to a study, the global self-monitoring blood glucose devices market size was worth around USD 19.76 Billion in 2024 and is expected to reach USD 59.53 Billion by 2034.
The global self-monitoring blood glucose devices market is expected to grow at a CAGR of 11.66% during the forecast period.
North America is expected to dominate the self-monitoring blood glucose devices market over the forecast period.
Leading players in the global self-monitoring blood glucose devices market include Abbott Laboratories, Dexcom, Medtronic, Roche, Ascensia Diabetes Care, Senseonics, Nemaura Medical, Know Labs, BioXensor, DiaMonTech, among others.
The report explores crucial aspects of the self-monitoring blood glucose devices market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
HappyClients